Dr Mike Yeadon

by Dr Michael Yeadon and Marc Girardot As the SARS-CoV-2 epidemic continues across the globe, many genetic modifications have started to appear in the virus. These are being sequenced, analysed1 and monitored by many scientists. This well known phenomenon occurs continuously for Influenza as well as for coronaviruses. Health authorities and mainstream media have been very wary of supposed heightened risk profiles of these new variants. They are also adamant about a potential risk of evasion from immunity, whether that immunity was acquired via infection or vaccination. Some evolutionary virologists consider that viruses ‘attenuate’, or evolve towards less virulent forms. Some feel that novel pharmaceutical2 and non-pharmaceutical interventions3 – or specific circumstances4 – could possibly disrupt this evolutionary process and favour a more severe variant or threaten acquired immunity. The recent downward trends5 in cases and in hospitalisations across the globe seem to indicate that the virus has probably not mutated in any way that would make it much more dangerous and that a healthy immune system is very capable of dealing with these new forms of the SARS-CoV-2 virus. Indeed, patients have been shown to recover naturally in most instances just like they did from the original form of COVID-19.6 The paucity of confirmed re-infections with the virus, accompanied by clinical symptoms, despite hundreds of millions of infections over...

by Dr Mike Yeadon Chief Medical Officer, Professor Chris Whitty and Chief Scientific Adviser, Sir Patrick Vallance give a Coronavirus Data Briefing in 10 Downing Street on September 21st. Picture by Pippa Fowles / No 10 Downing Street. How a novel virus met a partly-immune population In Spring 2020 a novel coronavirus swept across the world: novel, but related to other viruses. In the UK, unknown at the time, around 50% of the population were already immune. The evidence for this is unequivocal and arose due to prior infection by common cold-causing coronaviruses (of which four are endemic). This prior immunity has been confirmed around the world by top cellular immunologists. There is even a very recent paper from Public Health England on the topic of prior immunity and a wealth of other evidence from studies on memory T-cells, studies on household transmission and on antibodies. Because of the extent of the prior immunity, and as a result of heterogeneity of contacts, once only a low percentage of the population, perhaps as low as 10-20% had been infected, “herd immunity” was established. This is why daily deaths, which were rising exponentially, turned abruptly and began to fall, uninterrupted by street protests, the return to work, the reopening of pubs and crowded beaches during the summer. (See this explainer by the...

by Dr Mike Yeadon A source just gave me the following information. A hospital in Wales, Nevill Hall in Abergavenny, has 250 beds. 200 beds are empty. The surgeons are bored and pass much time on the nearby golf course. I think this might be one answer to why UK doctors are not investigating to find out why hospitals have no patients in them! Apparently all Covid cases are currently being sent to this hospital. This story tallies with the original evidence which drew me into this ghastly mess we’ve made of our country. I’ve not mentioned this for quite a while but you all should be incandescent about it. A good friend who’s a Professor of Cell Biology was playing hockey many miles from home. He fell into conversation with one of the opposing team. This person is a fairly senior manger in NHS England and has daily sight of bed disposition across the service. He was upset to have realised that, as intensive care beds emptied because the many COVID-19 patients either recovered or sadly died, they were not being replaced by elective surgical patients. To the best of my recollection, this was late June. I was put in touch with the NHSE staffer by my friend, because he knew I was, by then, telling him all the...

by Mike Yeadon Chief Medical Officer, Professor Chris Whitty, and Chief Scientific Adviser, Sir Patrick Vallance, give a Coronavirus Data Briefing in 10 Downing Street. Picture by Pippa Fowles/No 10 Downing Street. “It’s Easier to Fool People Than It Is to Convince Them That They Have Been Fooled.” – Mark Twain Dr Mike Yeadon has a degree in biochemistry and toxicology and a research-based PhD in respiratory pharmacology. He has spent over 30 years leading new medicines research in some of the world's largest pharmaceutical companies, leaving Pfizer in 2011 as Vice President & Chief Scientist for Allergy & Respiratory. That was the most senior research position in this field in Pfizer. Since leaving Pfizer, Dr Yeadon has founded his own biotech company, Ziarco, which was sold to the worlds biggest drug company, Novartis, in 2017. Abstract SAGE made – and continues to make – two fatal errors in its assessment of the SAR-CoV-2 pandemic, rendering its predictions wildly inaccurate, with disastrous results. These errors led SAGE to conclude that the pandemic is still in its early stages, with the vast majority (93%) of the UK population remaining susceptible to infection and that, in the absence of more action, a very high number of deaths will occur. Error 1: Assuming that 100% of the population was susceptible to the virus...

by Dr Michael Yeadon I never expected to be writing something like this. I am an ordinary person, recently semi-retired from a career in the pharmaceutical industry and biotech, where I spent over 30 years trying to solve problems of disease understanding and seek new treatments for allergic and inflammatory disorders of lung and skin. I’ve always been interested in problem solving, so when anything biological comes along, my attention is drawn to it. Come 2020, came SARS-CoV-2. I’ve written about the pandemic as objectively as I could. The scientific method never leaves a person who trained and worked as a professional scientist. Please do read that piece. My co-authors & I will submit it to the normal rigours of peer review, but that process is slow and many pieces of new science this year have come to attention through pre-print servers and other less conventional outlets. While paying close attention to data, we all initially focused on the sad matter of deaths. I found it remarkable that, in discussing the COVID-19 related deaths, most people I spoke to had no idea of large numbers. Asked approximately how many people a year die in the UK in the ordinary course of events, each a personal tragedy, They usually didn’t know. I had to inform them it is around 620,000, sometimes...